Can tizanidine be used safely together with cyclosporine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Tizanidine and Cyclobenzaprine Be Used Together?

Yes, tizanidine and cyclobenzaprine can generally be used together, but this combination requires caution due to additive CNS depressant effects including increased sedation, somnolence, and hypotension risk. There are no documented pharmacokinetic interactions between these two muscle relaxants, and they work through different mechanisms (tizanidine as an alpha-2 adrenergic agonist, cyclobenzaprine as a centrally-acting muscle relaxant with tricyclic structure).

Key Clinical Considerations

Additive CNS Depression

The primary concern with combining these agents is additive central nervous system depression 1. Tizanidine's FDA label explicitly warns that sedation may be additive when taken with other CNS depressants including baclofen and benzodiazepines 1. While cyclobenzaprine is not specifically mentioned, it shares similar CNS depressant properties.

Cardiovascular Monitoring

Monitor blood pressure closely when using this combination:

  • Tizanidine can cause clinically significant orthostatic hypotension 1
  • Recent evidence shows tizanidine can cause profound hypotension, particularly when combined with antihypertensive agents 2
  • Bradycardia is another potential adverse effect of tizanidine as an alpha-2 agonist 1

Practical Management Algorithm

If considering combination therapy:

  1. Start low, go slow: Begin with the lowest effective doses of each agent
  2. Stagger administration: Consider giving doses at different times to minimize peak additive effects
  3. Patient counseling: Warn about:
    • Increased drowsiness and sedation
    • Risk of falls (particularly in elderly)
    • Avoiding alcohol and other CNS depressants
    • Not driving or operating machinery until effects are known 1
  4. Monitor for:
    • Excessive sedation or somnolence
    • Hypotension (especially orthostatic)
    • Bradycardia
    • Increased fall risk

Important Caveats

Avoid this combination in:

  • Elderly patients (higher fall risk)
  • Patients with baseline hypotension or bradycardia
  • Those taking multiple antihypertensive medications 2
  • Patients with hepatic impairment (both drugs are hepatically metabolized)
  • Those operating vehicles or heavy machinery

Drug interaction note: While there's no direct tizanidine-cyclobenzaprine interaction, be aware that tizanidine has significant interactions with CYP1A2 inhibitors (ciprofloxacin, fluvoxamine) that can dramatically increase tizanidine levels and hypotension risk 3, 4. This is separate from cyclobenzaprine considerations but critical for overall medication management.

Alternative Approach

Consider monotherapy first with either agent titrated to optimal effect before adding a second muscle relaxant. If spasticity control is inadequate with one agent, tizanidine combined with baclofen has been studied and shows no significant pharmacokinetic interaction 5, though CNS depression remains a concern with that combination as well.

The combination is not contraindicated, but requires vigilant monitoring and patient education about additive sedative and hypotensive effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.